ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2022 Congress

Coagulation and Natural Anticoagulants » Coagulation Factors and Inhibitors

Theme Navigation

  • ISTH 2022 Congress
    • Coagulation and Natural Anticoagulants
      • Coagulation Factors and Inhibitors

Abstract Number: PB0552

A Probable Therapeutic for a Child with Inherited Protein S Deficiency

V. Pereira1, L. Thangada2, M. khosla3, r. majumder4

Abstract Number: VPB0572

A study of the stability of fibrinogen and FXIII levels and microbial integrity of pooled cyroprecipitate stored at 1-6°C and 20-24°C for up to 120 hours

H. Kaur1, A. Ang1, S. Chua1, P. Shu1, C. Tan2, W. Wong2

Abstract Number: OC 36.4

A Tethered Artificial Protease Reveals the Location of Key Regulatory Motifs in Factor V

F. Ayombil1, R. Toso1, R. Camire2

Abstract Number: PB0548

Abelacimab, a Factor XI/XIa Antibody Inhibits Clotting in Hemodialysis Circuits Ex Vivo

K. Kovacevic1, C. Schörgenhofer2, G. Langer2, Y. Khder3, B. Jilma2, J. Grafeneder4

Abstract Number: OC 65.2

Andexanet alfa is associated with a significant reduction in in-hospital mortality compared to 4F-PCC in a real-world analysis

P. Dobesh1, C. Coleman2, J. Ulloa3, B. Lovelace4, T. Dettling4, B. Koch4, G. Fermann5

Abstract Number: PB0547

Antithrombin deficiency is associated with more compact plasma fibrin clot structure and impaired susceptibility to fibrinolysis

A. Klajmon1, M. Kopytek2, J. Natorska3, A. Undas1, M. Ząbczyk3

Abstract Number: VPB0570

Assessment of Impact of Metabolites of Edoxaban and Dabigatran on Fibrin and Thrombin Generation Assays

J. Evrard1, R. Siriez1, V. Maloteau1, J. Dogné2, J. Douxfils3

Abstract Number: PB0542

Bio-equivalence of Potency adjusted approved heparin solutions compared to a newly developed heparin solution.

E. Krupa1, D. Hoppensteadt2, W. Jeske1, A. Farooqui1, A. Kouta1, O. Iqbal1, B. Kantarcioglu3, R. Krämer4, J. Fareed2

Abstract Number: PB0561

Ca2+ and Zn2+ binding to human Protein Z (PZ) induces structural changes that augments its lipid binding

T. Sengupta1, S. Gayathri2, S. Gupta3

Abstract Number: PB0564

Combined Molecular Dynamics and Docking Studies on Direct Oral Anticoagulant Binding to Factor Xa Variants

D. Veizaj1, D. Poole III2, M. Schreuder3, P. Reitsma4, D. Verhoef4, D. Geerke5, M. Bos6

Abstract Number: PB0549

Comparative Studies on Clotting and Antiprotease Profile of Heparins of Ovine, Bovine and Porcine Origin

E. Krupa1, J. Lewis2, A. Farooqui1, O. Iqbal1, W. Jeske1, J. Walenga1, Y. Yao3, J. Fareed4

Abstract Number: VPB0567

Comparative Studies on the Interaction of Heparins from Various Origins with Heparin Cofactor II and Antithrombin

N. Baig1, A. Kouta1, M. Jaradeh2, D. Hoppensteadt3, W. Jeske1, J. Fareed3

Abstract Number: OC 67.4

Congenital factor VII deficiency in a large cohort of Portuguese patients — molecular profiling, pathogenicity stratification and genotype-phenotype correlation

C. Silva Pinto1, I. Rocha2, C. Catarino3, R. Salvado4, M. Costa5, F. Rodrigues6, S. Nobre Fernandes7, C. Geraldes8, T. Fidalgo9

Abstract Number: PB0532

Deciphering the role of small sulfated molecule PTS on AT3 structure and in vitro clot formation.

I. Ahmad1, M. Abid2, S. Deep3, M. Jairajpuri4

Abstract Number: PB0550

Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa

J. Lewis1, O. Iqbal2, W. Jeske2, D. Hoppensteadt3, F. Siddiqui2, B. Lewis2, J. Fareed3

Abstract Number: PB0557

Effectiveness and safety of Direct Oral Anticoagulants (DOACs) in extremely obese compared to non-extremely obese patients in an observational prospective single-centre unselected patient registry

C. Moret Puig1, S. Mojal2, M. Plaza Seijas3, R. Acosta-Isaac4, J. Souto5

Abstract Number: PB0545

Efficacy and safety of Haemocer, a local hemostatic agent, in patients with congenital bleeding disorders: A pilot study

M. Karimi1, S. Haghpanah2, N. Javanmardi2, H. Tavoosi3, S. Kamalian Fard2, N. Momtahan2

Abstract Number: PB0538

Enzymatic activity of bound thrombin within fibrin fibers

J. Crossen1, S. Diamond2

Abstract Number: VPB0569

Evaluation of the FibWave in Edoxaban and Healthy Samples, a Comparison with the APTT- and PT-based Clot Waveform Analysis

J. Evrard1, R. Siriez1, J. Dogné2, J. Douxfils3

Abstract Number: PB0536

Ex vivo study of the concomitant use of plasma-derived Factor VIII/Von Willebrand Factor and emicizumab in patients with severe Hemophilia A

M. Bravo1, A. Raventós1, A. Pérez1, E. Arias Salgado2, M. Alvarez-Román3, N. Butta2, V. Jiménez Yuste4, M. Costa1, T. Willis5

  • 1
  • 2
  • 3
  • Next Page »

« View all themes from the ISTH 2022 Congress

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley